Anlon Healthcare Limited is a chemical manufacturer specializing in (i) high-purity pharmaceutical intermediates, used as key starting materials for APIs, and (ii) active pharmaceutical ingredients (APIs), which are essential for formulations like tablets, capsules, ointments, syrups, nutraceuticals, personal care, and veterinary products. Its portfolio covers pharmaceutical intermediates, APIs, nutraceutical APIs, and ingredients for personal care and animal health. All APIs are produced in compliance with Indian and international pharmacopeia standards, including IP, BP, EP, JP, and USP, ensuring global quality benchmarks.
Price Band₹86 - ₹91 |
Dates26 Aug - 29 Aug |
GMP₹2 (2.20%) |
Subscriptions- |
Issue Size₹127.40 Crs |
26 Aug 25
29 Aug 25
01 Sep 25
02 Sep 25
02 Sep 25
03 Sep 25
Price Band₹86 - ₹91 |
Listing AtNSE & BSE |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹127.40 Cr (1.40 Cr Shares) |
Offer For Sale₹0.00 (0.00 Shares) |
Total Issue₹127.40 Cr (1.40 Cr Shares) |
Face Value₹10 per equity share |
| Investor Category | Lot | Shares | Amount | |
|---|---|---|---|---|
| Retail |
Minimum
1
164
14,924
Maximum
13
2,132
1,94,012
|
|||
| Small HNI |
Minimum
14
2,296
2,08,936
Maximum
67
10,988
9,99,908
|
|||
| Big HNI |
Minimum
68
11,152
10,14,832
|
|||
The estimated Grey Market Premium of Anlon Healthcare IPO is ₹2 per share (2.20%)
| Particulars | Allocation |
|---|---|
| QIB | Not less than 75% of Net Offer |
| Big HNIs (NII) | Not more than 10% of Net Offer |
| Small HNIs (NII) | Not more than 5% of Net Offer |
| Retail | Not more than 10% of Net Offer |
| Particulars | Jan-25 | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|---|
| Revenue from Operations | 77.25 | 66.58 | 112.88 | 57.14 |
| Profit after Tax | 11.96 | 9.66 | 5.82 | -0.11 |
| Net Worth | 71.86 | 21.03 | 7.37 | 1.55 |
| Total Borrowing | 62.39 | 74.56 | 66.39 | 60.32 |
| Total Assets | 160.96 | 128.00 | 111.55 | 84.97 |
| NAV per share (in ₹) | 18.03 | 13.14 | 6.15 | 1.30 |
| EPS - Basic (in ₹) | 4.65 | 6.68 | 4.85 | -0.09 |
The financial information presented is on a consolidated basis.
| KPI | Values |
|---|---|
| EBITDA | 23.35% |
| PAT | 14.50% |
| RONW | 45.92% |
| ROCE | 16.29% |
| Debt to Equity | 3.55 |
| PE Ratio | 13.62 |
| PB Ratio | 6.93 |
| Mkt Cap (in Crs.) | 490.05 |
All the data pertains to FY 2023-24.PE, PB, and market capitalization are calculated based on the Upper Price Band.
| Particulars | Anlon Healthcare | Kronox Lab | Ami Organics | Supriya Lifeciences |
|---|---|---|---|---|
| Revenue from Ops (in Crs.) | 66.58 | 86.86 | 687.58 | 570.37 |
| PAT (In Crs.) | 9.66 | 21.35 | 43.68 | 119.11 |
| EPS - Basic | 6.68 | 5.81 | 11.91 | 14.80 |
| NAV per share | 13.14 | 17.87 | 183.05 | 101.31 |
| RONW | 45.92% | 32.20% | 6.47% | 14.61% |
| EBITDA | 23.35% | 32.70% | 12.79% | 31.60% |
| PAT Margin | 14.50% | 24.00% | 6.34% | 20.50% |
| Price to earning (PE) | 13.62 | 26.72 | 197.70 | 49.52 |
All information pertains to FY 2023-24. The PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of April 15, 2025 for Peers
| Particulars | Anlon Healthcare |
|---|---|
| Revenue from Ops (in Crs.) | 66.58 |
| PAT (In Crs.) | 9.66 |
| EPS - Basic | 6.68 |
| NAV per share | 13.14 |
| RONW | 45.92% |
| EBITDA | 23.35% |
| PAT Margin | 14.50% |
| Price to earning (PE) | 13.62 |
| Kronox Lab | Ami Organics | Supriya Lifeciences |
|---|---|---|
| 86.86 | 687.58 | 570.37 |
| 21.35 | 43.68 | 119.11 |
| 5.81 | 11.91 | 14.80 |
| 17.87 | 183.05 | 101.31 |
| 32.20% | 6.47% | 14.61% |
| 32.70% | 12.79% | 31.60% |
| 24.00% | 6.34% | 20.50% |
| 26.72 | 197.70 | 49.52 |
All information pertains to FY 2023-24. The PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of April 15, 2025 for Peers
| Name | Shareholding |
|---|---|
| Punitkumar Rasadia | 46.65% |
| Meet Vachhani | 23.61% |
| Total | 70.26% |
| Name | Designation |
|---|---|
| Punitkumar Rasadia | Chairman & MD |
| Hitesh Makwana | CFO |
Name: Anlon Healthcare Limited
Address: 101/102, Silvercoin Complex, Opp.Crystal Mall, Kalawad Road Rajkot – 360 005, Gujarat, India
Number: +91 281 2562538/39
Email: cs@anloncro.co
Frequently Asked questions?
Find answers to common questions that come in your mind related to IPO.
Anlon Healthcare IPO is a Mainboard IPO having an issue size of Rs. ₹127.40 Crs. Anlon Healthcare IPO is priced at ₹86 - ₹91 per share. The issue opens on 26 Aug 25 and closes on 29 Aug 25.
Anlon Healthcare IPO opens on 26 Aug 25 and closes on 29 Aug 25.
The estimated Grey Market Premium of Anlon Healthcare IPO is ₹2 per share (2.20%).
The minimum lot size of Anlon Healthcare IPO is 164 shares & the minimum application amount is Rs. 14924.
The allotment date of Anlon Healthcare IPO is 01 Sep 25.
The listing date of Anlon Healthcare IPO is 03 Sep 25.
Anlon Healthcare IPO is subscribed -.
Anlon Healthcare IPO is priced at ₹86 - ₹91 per share.
Click the allotment link on Anlon Healthcare IPO page of IPO360.